Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm, open-label, phase 2 trial
出版年份 2021 全文链接
标题
Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm, open-label, phase 2 trial
作者
关键词
-
出版物
LANCET ONCOLOGY
Volume 22, Issue 11, Pages 1609-1617
出版商
Elsevier BV
发表日期
2021-10-06
DOI
10.1016/s1470-2045(21)00460-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial
- (2021) Yunpeng Yang et al. LANCET ONCOLOGY
- Management and risk factors of recurrent gestational trophoblastic neoplasia: An update from 2004 to 2017
- (2020) Yujia Kong et al. Cancer Medicine
- Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study
- (2020) Jing Huang et al. LANCET ONCOLOGY
- Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial
- (2020) Jieqiong Liu et al. Journal for ImmunoTherapy of Cancer
- Avelumab in Patients With Gestational Trophoblastic Tumors With Resistance to Single-Agent Chemotherapy: Cohort A of the TROPHIMMUN Phase II Trial
- (2020) Benoit You et al. JOURNAL OF CLINICAL ONCOLOGY
- Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
- (2020) Chunyan Lan et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunotherapy Versus Chemotherapy for Methotrexate-Resistant Low-Risk Gestational Trophoblastic Neoplasia
- (2020) John R. Lurain et al. JOURNAL OF CLINICAL ONCOLOGY
- Camrelizumab Plus Apatinib in Extensive-Stage SCLC (PASSION): A Multicenter, Two-Stage, Phase 2 Trial
- (2020) Yun Fan et al. Journal of Thoracic Oncology
- PD ‐L1, B7‐H3 and VISTA are highly expressed in gestational trophoblastic neoplasia
- (2019) Liju Zong et al. HISTOPATHOLOGY
- Placental site trophoblastic tumor and epithelioid trophoblastic tumor: Clinical and pathological features, prognostic variables and treatment strategy
- (2019) Angiolo Gadducci et al. GYNECOLOGIC ONCOLOGY
- When to stop human chorionic gonadotrophin (hCG) surveillance after treatment with chemotherapy for gestational trophoblastic neoplasia (GTN): A national analysis on over 4,000 patients
- (2019) Kirsty Balachandran et al. GYNECOLOGIC ONCOLOGY
- Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
- (2019) Nadeem R. Abu-Rustum et al. Journal of the National Comprehensive Cancer Network
- Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma
- (2018) Jing Huang et al. CLINICAL CANCER RESEARCH
- Management and prognosis of patients with liver metastases from gestational trophoblastic neoplasia: a retrospective cohort study
- (2018) Liju Zong et al. Cancer Management and Research
- Anti-PD-1 Antibody SHR-1210 Combined with Apatinib for Advanced Hepatocellular Carcinoma, Gastric, or Esophagogastric Junction Cancer: An Open-label, Dose Escalation and Expansion Study
- (2018) Jianming Xu et al. CLINICAL CANCER RESEARCH
- Update on the diagnosis and management of gestational trophoblastic disease
- (2018) Hextan Y.S. Ngan et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Clinical characteristics and prognosis of ultra high-risk gestational trophoblastic neoplasia patients: A retrospective cohort study
- (2017) Yujia Kong et al. GYNECOLOGIC ONCOLOGY
- PD-L1 Expression in Premalignant and Malignant Trophoblasts From Gestational Trophoblastic Diseases Is Ubiquitous and Independent of Clinical Outcomes
- (2017) Pierre-Adrien Bolze et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia
- (2017) Ehsan Ghorani et al. LANCET
- Management and prognosis of patients with brain metastasis from gestational trophoblastic neoplasia: a 24-year experience in Peking union medical college hospital
- (2015) Changji Xiao et al. BMC CANCER
- Contribution of PD-L1 to oncogenesis of lymphoma and its RNAi-based targeting therapy
- (2012) Yi Li et al. LEUKEMIA & LYMPHOMA
- Prognosis of patients with relapsed and chemoresistant gestational trophoblastic neoplasia transferred to the Peking Union Medical College Hospital
- (2009) F Feng et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started